Patrys Limited , a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.
http://www.news-medical.net/news/20131129/Patrys-to-present-data-from-PAT-SM6-Phase-IIIa-trial-in-multiple-myeloma-at-ASH-conference.aspx
http://www.news-medical.net/news/20131129/Patrys-to-present-data-from-PAT-SM6-Phase-IIIa-trial-in-multiple-myeloma-at-ASH-conference.aspx
No comments:
Post a Comment